Online Consultation with Oncologist Doctors Abroad — Page 4

Prof. Enriqueta Felip is the President of the Oncology Commission at Vall d’Hebron University Hospital. She provides online consultations for patients with lung cancer and thoracic malignancies.

• Received the first ESMO Women for Oncology Award for her professional leadership
• Professor of Medicine at the Universitat de Vic training future oncologists
• Leads clinical trials investigating new therapies and pharmacogenomic methods for personalized care
• Board member of the International Association for the Study of Lung Cancer (IASLC)
• Vice-President of the Spanish Society of Medical Oncology (SEOM) until recently

Dr. Ali Ihsan Anadolulu leads internal medicine at Central Hospital. He provides online consultations for patients seeking expert guidance on complex digestive and oncologic issues.

• Trained at Istanbul University Cerrahpaşa – one of Turkey's most prestigious medical schools
• Specializes in gastroenterology and internal medicine to address systemic health concerns
• Performs advanced endoscopic procedures for precise diagnostic evaluations
• Authored numerous scientific publications and textbooks to educate other physicians
• Focuses on pediatric gastrointestinal surgery and minimally invasive techniques

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Auala Hubert heads the Gastrointestinal Cancer Center at Hadassah Medical Center. He provides online consultation with oncologist services for digestive system tumors.

• Dual-qualified as a medical oncologist and a radiotherapist
• Specializes in esophagus, stomach, pancreas, and colon cancers
• Expert in HIPEC – delivering heated chemotherapy directly into the abdomen
• Certified by the American USMLE for high medical standards
• Member of the Israel Society of Clinical Oncology

Professor Rifaat Safadi heads the Liver Disease Unit at Hadassah Medical Center. He specializes in gastrointestinal disorders and liver cancer during his online oncologist consultations.

• Treats liver cancer, cirrhosis, and liver metastases using advanced therapies
• Experienced in radioembolization and liver resection for hepatic malignancies
• Winner of the Hadassah Prize for research on liver fibrosis
• Served a fellowship in liver diseases at the Sinai School of Medicine
• Member of the Israeli Association of Gastroenterology and Hepatology

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist at Shefaa Al Orman Hospital. He specializes in the diagnosis and surgical treatment of thoracic cancers. Dr. Al Demery is a Member of the Royal College of Surgeons of England. He holds a Doctorate in Surgical Oncology from the National Cancer Institute.

• Cofounder and member of the Egyptian Society of Respiratory Neoplasms.
• Performs complex lung resections, including lobectomy and pneumonectomy.
• Expert in esophageal cancer surgery and chest wall reconstruction.
• Works at an ESMO-accredited center treating 6,000 patients annually.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Francesc Bosch leads the experimental hematology laboratory at Vall d’Hebron Hospital. He offers online consultation with oncologist for chronic lymphocytic leukemia and lymphomas.

• Directs over 80 clinical trials testing new blood cancer drugs
• President of the Spanish Group for Chronic Lymphocytic Leukemia study
• Published over 100 articles in journals like Nature Medicine
• Specializes in molecular technologies to analyze hematological diseases
• Completed a post-doctoral fellowship at Columbia University in New York

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Ana Oaknin is the Co-Chair of the GEICO Group. She leads Spanish ovarian cancer research and coordinates national research teams.

• Heads the Gynecological Tumor Unit at Vall d Hebron University Hospital
• Authored 100 scientific publications on gynecological cancer and immunology
• Expert in DNA repair mechanisms during online consultation with oncologist
• Faculty member at the European Society of Medical Oncology (ESMO)
• Leads international clinical trials for novel gynecological tumor treatments

Dr. Jesus Soberino is a lead clinical oncologist at Hospital Quiron Barcelona. He specializes in breast cancer and melanoma during online consultations with oncologists.

• Researcher at the Vall d’Hebron Institute of Oncology (VHIO) in Spain
• Participated in clinical trials for immunotherapy and targeted hormone treatments
• Helped gain approval for CDK4/6 inhibitors palbociclib and ribociclib
• Collaborates with international groups to develop new cancer drugs
• Expert in overcoming hormone therapy resistance in metastatic breast cancer

Dr. Aleix Prat holds three patents in genomic medicine. He leads breast cancer programs at Hospital Clinic of Barcelona and IOB–Quiron Salud for online oncology consultations.

• President of the Board of SOLTI – a major Spanish breast cancer research group
• Expert in molecular subtypes – uses genetic markers to improve diagnostic accuracy for patients
• Author of over 160 publications including research on novel drug clinical trials
• Professor at the University of Barcelona directing the Breast Pathology Master's program
• Executive Committee member of the Breast International Group (BIG)

Prof. Beni Boursi is a leading specialist at Sheba Medical Center. He provides expert second opinions during an online consultation with an oncologist.

• Trained in gastrointestinal oncology at the University of Pennsylvania
• Completed elective medical oncology training at MD Anderson Cancer Center
• Founded the ECOG-ACRIN Microbiome Working Group to study cancer treatment response
• Developed predictive models for early diagnosis of colorectal and pancreatic cancers
• Published research in top-tier scientific journals including Science

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.